Alloy Therapeutics and Institute for Protein Innovation Announce Strategic Collaboration to Advance Next-Generation Antibody Discovery

AI Briefing

• – Alloy Therapeutics and Institute for Protein Innovation collaborate to advance antibody discovery with bespoke VHH libraries for next-gen therapeutics.
• – The partnership combines Alloy's integrated drug discovery and development capabilities with IPI's expertise in protein engineering and in vitro discovery.
• – The collaboration aims to power next-generation bispecific and multispecific therapeutics.